Owkin vs PostEra
OwkinDrug Discovery Platforms
CustomPublished price
PostEraDrug Discovery Platforms
CustomPublished price
Owkin Drug Discovery Platforms Building Biological Artificial Superintelligence | PostEra Drug Discovery Platforms Medicinal Chemistry Powered by Machine Learning | |
|---|---|---|
| Overview | ||
| Category | Drug Discovery Platforms | Drug Discovery Platforms |
| What it is | AI platform for drug discovery and diagnostics using federated learning on hospital data networks. | AI-powered medicinal chemistry platform that accelerates drug design through synthesis-aware generative chemistry and retrosynthesis. |
| Pricing | ||
| Published price | Custom Enterprise/partnership model with pharma and biotech; no public price list. Its K/K Pro agentic AI tools and R&D collaborations are sold via bespoke contracts and strategic allian… | Custom No public pricing; partnership/collaboration-based. PostEra engages pharma partners under drug-discovery deals (with Pfizer, Amgen and others) rather than a self-serve subscriptio… |
| Pricing model | Custom quote | Custom quote |
| Free options | No free plan · No free trial | No free plan · No free trial |
| Deal on Cubbie | None right now | None right now |
| Company | ||
| Founded | 2016 | 2019 |
| Team size | 201-500 employees | 51-200 employees |
| Headquarters | Paris, France | Boston, MA |